Cambridge University spin-out Owlsense to form its own medtech startup.

Owlsense, a spin-out of Cambridge University, is to form a new company to commercialise research into a breathalyser that can identify diseases. The medtech spin-out of Owlsense will be looking to raise somewhere between $3m-$5m to launch with, allowing Owlsense to continue its primary chemical detection nanochip business without being impeded by the breathalyser technology.…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.